Trial Identifier: | D3250C00029 |
Sponsor: | AstraZeneca |
NCTID:: | NCT02417961 |
Start Date: | April 2015 |
Primary Completion Date: | March 2016 |
Study Completion Date: | March 2016 |
Condition: | Asthma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Canada, AB | Calgary, AB, Canada |
Canada, BC | Vancouver, BC, Canada |
Canada, ON | Ajax, ON, Canada |
Canada, ON | Burlington, ON, Canada |
Canada, ON | Mississauga, ON, Canada |
Canada, ON | Toronto, ON, Canada |
Canada, QC | Pointe-Claire, QC, Canada |
Canada, QC | Quebec, QC, Canada |
Canada, QC | Quebec City, QC, Canada |
Canada, QC | St Charles Borromee, QC, Canada |
Canada, QC | Trois-Rivières, QC, Canada |
United States of America, CA | Fountain Valley, CA, United States of America |
United States of America, CA | Walnut Creek, CA, United States of America |
United States of America, FL | Celebration, FL, United States of America |
United States of America, FL | Ocala, FL, United States of America |
United States of America, FL | Orlando, FL, United States of America |
United States of America, FL | Winter Park, FL, United States of America |
United States of America, GA | Albany, GA, United States of America |
United States of America, MN | Minneapolis, MN, United States of America |
United States of America, MO | St Louis, MO, United States of America |
United States of America, NE | Bellevue, NE, United States of America |
United States of America, TX | San Antonio, TX, United States of America |